Analyze Diet

One Health approach for West Nile virus surveillance in the European Union: relevance of equine data for blood safety.

Abstract: West Nile virus (WNV) infection is notifiable in humans and equids in the European Union (EU). An area where a human case is detected is considered affected until the end of the mosquito transmission season (week 48) and blood safety measures have to be implemented. We used human and equine case notifications between 2013 and 2017 to define the WNV distribution in the EU and to investigate the relevance of using equine cases as a complementary trigger for blood safety measures. Adding areas with equine cases to the definition of an affected area would have a major impact on blood safety measures. Adding areas with equine cases where human cases have been reported in the past would increase the timeliness of blood safety measures with only a limited impact. Although the occurrence of human and/or equine cases confirms virus circulation in the EU, no evidence was found that occurrence of equine cases leads to human cases and vice versa. We conclude that information about equine data should contribute to raising awareness among public health experts and trigger enhanced surveillance. Further studies are required before extending the definition of affected areas to areas with human and/or equine cases.
Publication Date: 2019-04-25 PubMed ID: 31014416PubMed Central: PMC6826348DOI: 10.2807/1560-7917.ES.2019.24.16.1800349Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on the use of an integrated human and animal surveillance approach for West Nile virus (WNV) in the European Union (EU). It investigates the impact of considering regions with equine (horse) cases of WNV, alongside human cases, in implementing blood safety measures and defining affected regions.

Study Methodology and Findings

  • The research utilized data collected from notifications of human and equine cases of WNV infection between the years 2013 and 2017. In the present context, an area is deemed ‘affected’ by WNV once a single human case is detected, and effectively remains in this status till week 48 (the end of mosquito transmission season).
  • The study aimed to better characterize the geographical distribution of WNV in the EU and analyze the potential of including equine cases as a supplemental trigger for the implementation of blood safety measures.
  • Findings from the study suggested that including areas affected by equine cases in the definition of an ‘affected area’ would have profound implications on the application of blood safety measures.
  • Considering regions with equine cases where prior human reports exist could potentially increase the timeliness of blood safety measures, although the impact could be limited.

Evaluation and Future Research

  • The researchers noted that while the presence of human or equine cases confirms the circulation of the WNV within the EU, they found no evidence to suggest that the occurrence of equine cases leads to human cases or vice versa.
  • The study concludes that information regarding equine cases can play an important role in raising awareness among public health officials, and could be instrumental in initiating enhanced surveillance.
  • However, the research suggests that before expanding the definition of ‘affected areas’ to include regions with human and/or equine cases, further studies need to be undertaken to understand the potential implications and benefits of such an approach.

Cite This Article

APA
Young JJ, Coulombier D, Domanović D, Zeller H, Gossner CM. (2019). One Health approach for West Nile virus surveillance in the European Union: relevance of equine data for blood safety. Euro Surveill, 24(16), 1800349. https://doi.org/10.2807/1560-7917.ES.2019.24.16.1800349

Publication

ISSN: 1560-7917
NlmUniqueID: 100887452
Country: Sweden
Language: English
Volume: 24
Issue: 16
PII: 1800349

Researcher Affiliations

Young, Johanna J
  • European Centre for Disease Prevention and Control (ECDC), Stockholm.
Coulombier, Denis
  • European Centre for Disease Prevention and Control (ECDC), Stockholm.
Domanović, Dragoslav
  • European Centre for Disease Prevention and Control (ECDC), Stockholm.
Zeller, Hervé
  • European Centre for Disease Prevention and Control (ECDC), Stockholm.
Gossner, Céline M
  • European Centre for Disease Prevention and Control (ECDC), Stockholm.

MeSH Terms

  • Animals
  • Blood Safety
  • Culicidae / virology
  • Disease Notification / statistics & numerical data
  • Disease Outbreaks / veterinary
  • Disease Reservoirs / veterinary
  • European Union
  • Horse Diseases / virology
  • Horses
  • Humans
  • One Health
  • Public Health
  • Public Health Surveillance / methods
  • West Nile Fever / blood
  • West Nile Fever / prevention & control
  • West Nile Fever / virology
  • West Nile virus / pathogenicity

Conflict of Interest Statement

None declared.

References

This article includes 29 references
  1. Calistri P, Giovannini A, Hubalek Z, Ionescu A, Monaco F, Savini G, Lelli R. Epidemiology of west nile in europe and in the mediterranean basin.. Open Virol J 2010 Apr 22;4:29-37.
    doi: 10.2174/1874357901004010029pmc: PMC2878979pubmed: 20517490google scholar: lookup
  2. Pisani G, Cristiano K, Pupella S, Liumbruno GM. West Nile Virus in Europe and Safety of Blood Transfusion.. Transfus Med Hemother 2016 May;43(3):158-67.
    doi: 10.1159/000446219pmc: PMC4924479pubmed: 27403087google scholar: lookup
  3. Kramer LD, Li J, Shi PY. West Nile virus.. Lancet Neurol 2007 Feb;6(2):171-81.
    doi: 10.1016/S1474-4422(07)70030-3pubmed: 17239804google scholar: lookup
  4. Saegerman C, Alba-Casals A, García-Bocanegra I, Dal Pozzo F, van Galen G. Clinical Sentinel Surveillance of Equine West Nile Fever, Spain.. Transbound Emerg Dis 2016 Apr;63(2):184-93.
    doi: 10.1111/tbed.12243pubmed: 24899369google scholar: lookup
  5. European Centre for Disease Prevention and Control ECDC. West Nile virus risk assessment tool. Stockholm: ECDC; 2013.
  6. European Commission. Commission Decision 2007/875/EC amending Decision No 2119/98/EC of the European Parliament and of the Council and Decision 2000/96/EC as regards communicable diseases listed in those decisions. Official Journal of the European Union Luxembourg; 28 Dec 2007.
  7. European Commission. Commission Implementing Decision of 27 November 2012 amending Annexes I and II to Council Directive 82/894/EEC on the notification of animal diseases within the Community. Official Journal of the European Union Luxembourg; 29 Nov 2012.
  8. European Commission. Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Official Journal of the European Union Luxembourg; 6 Jul 2018.
  9. European Centre for Disease Prevention and Control ECDC. The European Surveillance System (TESSy). Stockholm: ECDC.
  10. European Centre for Disease Prevention and Control ECDC. West Nile fever. Annual epidemiological report for 2015 Stockholm: ECDC; 2017.
  11. European Commission. Commission Directive 2014/110/EU of 17 December 2014 amending Directive 2004/33/EC as regards temporary deferral criteria for donors of allogeneic blood donations. Official Journal of the European Union Luxembourg; 20 Dec 2014.
  12. European Centre for Disease Prevention and Control ECDC. Disease data from ECDC Surveillance Atlas - West Nile fever. Stockholm: ECDC.
  13. European Commission. Eurostat, NUTS- Nomenclature of Territorial Units for Statistics. Luxembourg: Eurostat.
  14. European Centre for Disease Prevention and Control ECDC. EMMa ECDC Map Maker Tool (EMMa). Stockholm: ECDC.
  15. Betsem E, Kaidarova Z, Stramer SL, Shaz B, Sayers M, LeParc G, Custer B, Busch MP, Murphy EL. Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012.. Emerg Infect Dis 2017 Feb;23(2):212-219.
    doi: 10.3201/eid2302.161058pmc: PMC5324803pubmed: 27935796google scholar: lookup
  16. Gossner CM, Marrama L, Carson M, Allerberger F, Calistri P, Dilaveris D, Lecollinet S, Morgan D, Nowotny N, Paty MC, Pervanidou D, Rizzo C, Roberts H, Schmoll F, Van Bortel W, Gervelmeyer A. West Nile virus surveillance in Europe: moving towards an integrated animal-human-vector approach.. Euro Surveill 2017 May 4;22(18).
  17. Lim SM, Koraka P, Osterhaus AD, Martina BE. West Nile virus: immunity and pathogenesis.. Viruses 2011 Jun;3(6):811-28.
    doi: 10.3390/v3060811pmc: PMC3185772pubmed: 21994755google scholar: lookup
  18. Kramer LD, Styer LM, Ebel GD. A global perspective on the epidemiology of West Nile virus.. Annu Rev Entomol 2008;53:61-81.
  19. Wilkins PA, Glaser AL, McDonnell SM. Passive transfer of naturally acquired specific immunity against West Nile Virus to foals in a semi-feral pony herd.. J Vet Intern Med 2006 Jul-Aug;20(4):1045-7.
  20. Beck C, Jimenez-Clavero MA, Leblond A, Durand B, Nowotny N, Leparc-Goffart I, Zientara S, Jourdain E, Lecollinet S. Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease.. Int J Environ Res Public Health 2013 Nov 12;10(11):6049-83.
    doi: 10.3390/ijerph10116049pmc: PMC3863887pubmed: 24225644google scholar: lookup
  21. Bahuon C, Marcillaud-Pitel C, Bournez L, Leblond A, Beck C, Hars J, Leparc-Goffart I, L'Ambert G, Paty MC, Cavalerie L, Daix C, Tritz P, Durand B, Zientara S, Lecollinet S. West Nile virus epizootics in the Camargue (France) in 2015 and reinforcement of surveillance and control networks.. Rev Sci Tech 2016 Dec;35(3):811-824.
    doi: 10.20506/rst.35.3.2571pubmed: 28332648google scholar: lookup
  22. Calzolari M, Pautasso A, Montarsi F, Albieri A, Bellini R, Bonilauri P, Defilippo F, Lelli D, Moreno A, Chiari M, Tamba M, Zanoni M, Varisco G, Bertolini S, Modesto P, Radaelli MC, Iulini B, Prearo M, Ravagnan S, Cazzin S, Mulatti P, Monne I, Bonfanti L, Marangon S, Goffredo M, Savini G, Martini S, Mosca A, Farioli M, Gemma Brenzoni L, Palei M, Russo F, Natalini S, Angelini P, Casalone C, Dottori M, Capelli G. West Nile Virus Surveillance in 2013 via Mosquito Screening in Northern Italy and the Influence of Weather on Virus Circulation.. PLoS One 2015;10(10):e0140915.
  23. Rizzo C, Napoli C, Venturi G, Pupella S, Lombardini L, Calistri P, Monaco F, Cagarelli R, Angelini P, Bellini R, Tamba M, Piatti A, Russo F, Palù G, Chiari M, Lavazza A, Bella A. West Nile virus transmission: results from the integrated surveillance system in Italy, 2008 to 2015.. Euro Surveill 2016 Sep 15;21(37).
  24. Alba A, Allepuz A, Napp S, Soler M, Selga I, Aranda C, Casal J, Pages N, Hayes EB, Busquets N. Ecological surveillance for West Nile in Catalonia (Spain), learning from a five-year period of follow-up.. Zoonoses Public Health 2014 May;61(3):181-91.
    doi: 10.1111/zph.12048pubmed: 23590452google scholar: lookup
  25. Pérez-Ramírez E, Llorente F, Jiménez-Clavero MÁ. Experimental infections of wild birds with West Nile virus.. Viruses 2014 Feb 13;6(2):752-81.
    doi: 10.3390/v6020752pmc: PMC3939481pubmed: 24531334google scholar: lookup
  26. Szentpáli-Gavallér K, Antal L, Tóth M, Kemenesi G, Soltész Z, Dán A, Erdélyi K, Bányai K, Bálint A, Jakab F, Bakonyi T. Monitoring of West Nile virus in mosquitoes between 2011-2012 in Hungary.. Vector Borne Zoonotic Dis 2014 Sep;14(9):648-55.
    doi: 10.1089/vbz.2013.1549pmc: PMC4171116pubmed: 25229703google scholar: lookup
  27. Castillo-Olivares J, Wood J. West Nile virus infection of horses.. Vet Res 2004 Jul-Aug;35(4):467-83.
    doi: 10.1051/vetres:2004022pubmed: 15236677google scholar: lookup
  28. Napoli C, Iannetti S, Rizzo C, Bella A, Di Sabatino D, Bruno R, Sauro F, Martini V, Santucci VU, Declich S, Calistri P. Vector borne infections in Italy: results of the integrated surveillance system for West Nile disease in 2013.. Biomed Res Int 2015;2015:643439.
    doi: 10.1155/2015/643439pmc: PMC4385594pubmed: 25874224google scholar: lookup
  29. European Centre for Disease Prevention and Control ECDC. Disease data from Animal Disease Notification System (ADNS) - Equine West Nile fever cases reported through ADNS. Stockholm: ECDC.

Citations

This article has been cited 16 times.
  1. McCarter MSJ, Self S, Dye-Braumuller KC, Lee C, Li H, Nolan MS. The utility of a Bayesian predictive model to forecast neuroinvasive West Nile virus disease in the United States of America, 2022.. PLoS One 2023;18(9):e0290873.
    doi: 10.1371/journal.pone.0290873pubmed: 37682897google scholar: lookup
  2. Constant O, Gil P, Barthelemy J, Bolloré K, Foulongne V, Desmetz C, Leblond A, Desjardins I, Pradier S, Joulié A, Sandoz A, Amaral R, Boisseau M, Rakotoarivony I, Baldet T, Marie A, Frances B, Reboul Salze F, Tinto B, Van de Perre P, Salinas S, Beck C, Lecollinet S, Gutierrez S, Simonin Y. One Health surveillance of West Nile and Usutu viruses: a repeated cross-sectional study exploring seroprevalence and endemicity in Southern France, 2016 to 2020.. Euro Surveill 2022 Jun;27(25).
  3. Stramer SL, Lanteri MC, Brodsky JP, Foster GA, Krysztof DE, Groves JA, Townsend RL, Notari E, Bakkour S, Stone M, Simmons G, Spencer B, Tonnetti L, Busch MP. Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction.. Transfusion 2022 Jul;62(7):1388-1398.
    doi: 10.1111/trf.16950pubmed: 35726756google scholar: lookup
  4. Nagy A, Csonka N, Takács M, Mezei E, Barabás É. West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019.. PLoS One 2022;17(4):e0266840.
    doi: 10.1371/journal.pone.0266840pubmed: 35395048google scholar: lookup
  5. Chowdhury P, Khan SA. Global emergence of West Nile virus: Threat & preparedness in special perspective to India.. Indian J Med Res 2021 Jul;154(1):36-50.
    doi: 10.4103/ijmr.IJMR_642_19pubmed: 34782529google scholar: lookup
  6. de Heus P, Kolodziejek J, Hubálek Z, Dimmel K, Racher V, Nowotny N, Cavalleri JV. West Nile Virus and Tick-Borne Encephalitis Virus Are Endemic in Equids in Eastern Austria.. Viruses 2021 Sep 19;13(9).
    doi: 10.3390/v13091873pubmed: 34578454google scholar: lookup
  7. Alzuheir I, Fayyad A, Jalboush N, Abdallah R, Abutarbush S, Gharaibeh M, Bdarneh M, Khraim N, Helal MA, Helal BA. Seroprevalence and risk factors of West Nile virus infection in veterinarians and horses in Northern Palestine.. Vet World 2021 May;14(5):1241-1246.
  8. Arfuso F, Giudice E, Di Pietro S, Piccione G, Giannetto C. Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus.. Animals (Basel) 2021 Feb 11;11(2).
    doi: 10.3390/ani11020477pubmed: 33670395google scholar: lookup
  9. García-Carrasco JM, Muñoz AR, Olivero J, Segura M, Real R. Predicting the spatio-temporal spread of West Nile virus in Europe.. PLoS Negl Trop Dis 2021 Jan;15(1):e0009022.
    doi: 10.1371/journal.pntd.0009022pubmed: 33411739google scholar: lookup
  10. Constant O, Bollore K, Clé M, Barthelemy J, Foulongne V, Chenet B, Gomis D, Virolle L, Gutierrez S, Desmetz C, Moares RA, Beck C, Lecollinet S, Salinas S, Simonin Y. Evidence of Exposure to USUV and WNV in Zoo Animals in France.. Pathogens 2020 Nov 30;9(12).
    doi: 10.3390/pathogens9121005pubmed: 33266071google scholar: lookup
  11. Vilibic-Cavlek T, Petrovic T, Savic V, Barbic L, Tabain I, Stevanovic V, Klobucar A, Mrzljak A, Ilic M, Bogdanic M, Benvin I, Santini M, Capak K, Monaco F, Listes E, Savini G. Epidemiology of Usutu Virus: The European Scenario.. Pathogens 2020 Aug 26;9(9).
    doi: 10.3390/pathogens9090699pubmed: 32858963google scholar: lookup
  12. Schoenenwald AKJ, Gwee CP, Stiasny K, Hermann M, Vasudevan SG, Skern T. Development and characterization of specific anti-Usutu virus chicken-derived single chain variable fragment antibodies.. Protein Sci 2020 Nov;29(11):2175-2188.
    doi: 10.1002/pro.3937pubmed: 32829514google scholar: lookup
  13. Pervanidou D, Vakali A, Georgakopoulou T, Panagiotopoulos T, Patsoula E, Koliopoulos G, Politis C, Stamoulis K, Gavana E, Pappa S, Mavrouli M, Emmanouil M, Sourvinos G, Mentis A, Tsakris A, Hadjichristodoulou C, Tsiodras S, Papa A. West Nile virus in humans, Greece, 2018: the largest seasonal number of cases, 9 years after its emergence in the country.. Euro Surveill 2020 Aug;25(32).
  14. Özçelik R, Graubner C, Remy-Wohlfender F, Dürr S, Faverjon C. Evaluating 5.5 Years of Equinella: A Veterinary-Based Voluntary Infectious Disease Surveillance System of Equines in Switzerland.. Front Vet Sci 2020;7:327.
    doi: 10.3389/fvets.2020.00327pubmed: 32695799google scholar: lookup
  15. . The European Union One Health 2018 Zoonoses Report.. EFSA J 2019 Dec;17(12):e05926.
    doi: 10.2903/j.efsa.2019.5926pubmed: 32626211google scholar: lookup
  16. de Heus P, Kolodziejek J, Camp JV, Dimmel K, Bagó Z, Hubálek Z, van den Hoven R, Cavalleri JV, Nowotny N. Emergence of West Nile virus lineage 2 in Europe: Characteristics of the first seven cases of West Nile neuroinvasive disease in horses in Austria.. Transbound Emerg Dis 2020 May;67(3):1189-1197.
    doi: 10.1111/tbed.13452pubmed: 31840920google scholar: lookup